维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Muck W"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Bioanalytics of nimodipine-an overview of methods 显示文摘	Muck W Bode H	1994	Pharmazie1994，49，23：	1
2	Pharmacokinetics of crivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearance显示文摘	Vormfelde SV Muck W Freudenthaler SM	1999	J Clin Pharmacol1999，39，2：	1
3	Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry ( LC/MS/MS ) 显示文摘	Muck W	1999	Pharmazie1999，，9：	1
4	Metabolism of monocrotophos in animals 显示文摘	Mucke W	1994	Rev Environ Contain Toxicol1994，139，1：	1
5	Influence of the antacid Maalox and theHz-antagonist cimetidine on the pharmacokinetics of cerivastatin显示文摘	Muck W Ritter W Dietrich H	1997	Int J ClinPharmacol Ther1997，，：	1
6	Absolute and relative bioavailability of theHMG-CoA reductase inhibitor cerivastatin显示文摘	Muck W Ritter W Ochmann K	1997	Int J Clin Pharmacol Ther1997，，：	1
7	Liquid junction coupling for capillary zone electrophoresis/ion spray mass speetrometry显示文摘	LEE E D MUCK W HENION J D	1989	Biomed Environ Mass Speetrom1989，18，9：	1
8	Bee venom peptides XV Ⅲ,peptidem and mcd-peptide:isolation and characterization显示文摘	Mucke H W	1977	Int J Pept Protein Res1977，9，1：	1
9	Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique显示文摘	Fischer C Schonberger F Muck W	1993	J Pharm Sci1993，82，3：	1
10	Clinical pharmacological strategies to assess drug interaction potential during drug development显示文摘	Kuhlmann J Muck W	2001	Drug safety2001，24，10：	1
11	Metabolism of monocrotophos in animals 显示文摘	Mucke W	1994	Rev Environ Contam Toxicol1994，139，1：	1
12	Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin显示文摘	Riter W Ochmann K	1997	Int J Clin Pharmacol Ther1997，35，6：	1
13	Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recip- ients显示文摘	MUck W Mai I Fritsche L	1999	Clin Pharmacol Ther1999，65，3：	1
14	Influence of the antacid maalox and the H2 antagonist cimetidine on the pharmacokinatics of cerivastatin显示文摘	Riter W Dietrich H	1997	Int J Clin Pharmacol Ther1997，35，6：	1
15	Influence of erythromycin pre-and co-treatment of single dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin显示文摘	Ochmann K Rohde G	1998	Eur J Clin Pharmacol1998，53，6：	1
16	Influence of cholestyramine on the pharmacokinetics of cerivastatin显示文摘	Riter W Frey R	1997	Int J Clin Pharmacol Ther1997，35，6：	1
17	Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or evening显示文摘	Muck W Frey R Unger S Voith B	2000	Int J Clin Pharmacol Ther2000，38，：	1
18	Effects of manure storage design on nitrogen conservation 显示文摘	Muck R E Guest R W Richards B K	1984	Agricultural Wastes1984，，10：	1
19	Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique 显示文摘	Fischer C Schonberger F Muck W	1993	J Pharm Sci1993，82，：	1
20	Liquid junction coupling for capillary zone electrophoresis ion spray mass spectrometry显示文摘	Lee E D Muck W Heni N J D	1989	Biomed Environ Mass Spectrom1989，18，9：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示